Pharmaceutical companies by today's price change
How far the share price has moved since the previous close.
Spyre Therapeutics leads the 61 pharmaceutical companies ranked by today's price change, at +7.20%, ahead of BioMarin Pharmaceutical (+4.95%) and TG Therapeutics (+4.61%). Figures as of 18 Nov 2026, 19:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Spyre Therapeutics+7.20%
- Median
- -0.71%
- Combined market value
- NOK 49.05T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | +7.20% | NOK 92.6B | NOK 975.03 | 7.20% up | 286% up | ||
| 2 | BioMarin PharmaceuticalBMRN · Health Care | +4.95% | NOK 115.3B | NOK 595.39 | 4.95% up | 11% up | ||
| 3 | TG TherapeuticsTGTX · Health Care | +4.61% | NOK 96.1B | NOK 636.06 | 4.61% up | 107% up | ||
| 4 | Elanco Animal HealthELAN · Health Care | +3.85% | NOK 130.1B | NOK 260.29 | 3.85% up | 20% up | ||
| 5 | Amneal PharmaceuticalsAMRX · Health Care | +3.24% | NOK 73.7B | NOK 211.42 | 3.24% up | 83% up | ||
| 6 | Ionis PharmaceuticalsIONS · Health Care | +3.13% | NOK 44.9B | NOK 269.60 | 3.13% up | 64% down | ||
| 7 | ZoetisZTS · Health Care | +2.70% | NOK 337.7B | NOK 831.24 | 2.70% up | 29% down | ||
| 8 | Jazz PharmaceuticalsJAZZ · Health Care | +2.49% | NOK 153.5B | NOK 2,392.11 | 2.49% up | 37% up | ||
| 9 | Rhythm PharmaceuticalsRYTM · Health Care | +2.14% | NOK 80.1B | NOK 1,154.90 | 2.14% up | 13% up | ||
| 10 | AlkermesALKS · Health Care | +2.05% | NOK 75.6B | NOK 449.70 | 2.05% up | 58% up | ||
| 11 | ABIVAXABVX · Health Care | +1.86% | NOK 71B | NOK 810.82 | 1.86% up | 27% down | ||
| 12 | Ligand PharmaceuticalsLGND · Health Care | +1.65% | NOK 57.9B | NOK 2,895.82 | 1.65% up | 43% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | +1.37% | NOK 147B | NOK 754.84 | 1.37% up | 17% up | ||
| 14 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.36% | NOK 121.2B | NOK 145.36 | 1.36% up | 5% up | ||
| 15 | Protagonist TherapeuticsPTGX · Health Care | +1.05% | NOK 79.7B | NOK 1,221.51 | 1.05% up | 46% up | ||
| 16 | Royalty PharmaRPRX · Health Care | +0.92% | NOK 386.4B | NOK 672.03 | 0.92% up | 78% up | ||
| 17 | Arrowhead PharmaceuticalsARWR · Health Care | +0.81% | NOK 59.4B | NOK 420.23 | 0.81% up | 10% up | ||
| 18 | ViatrisVTRS · Health Care | +0.78% | NOK 229.1B | NOK 199.84 | 0.78% up | 96% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +0.61% | NOK 58.6B | NOK 897.03 | 0.61% up | 31% up | ||
| 20 | Vertex PharmaceuticalsVRTX · Health Care | +0.55% | NOK 1.32T | NOK 5,208.33 | 0.55% up | 27% up | ||
| 21 | Legend BiotechLEGN · Health Care | +0.43% | NOK 30.4B | NOK 156.88 | 0.43% up | 42% down | ||
| 22 | Cogent BiosciencesCOGT · Health Care | +0.34% | NOK 47.1B | NOK 270.96 | 0.34% up | 20% down | ||
| 23 | Praxis Precision MedicinesPRAX · Health Care | +0.28% | NOK 82.9B | NOK 2,966.07 | 0.28% up | 61% up | ||
| 24 | Abbott LaboratoriesABT · Health Care | -0.12% | NOK 1.76T | NOK 1,014.01 | 0.12% down | 17% down | ||
| 25 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | -0.18% | NOK 72.3B | NOK 920.54 | 0.18% down | 126% up | ||
| 26 | Ascendis PharmaASND · Health Care | -0.21% | NOK 172.1B | NOK 2,624.04 | 0.21% down | 28% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | -0.43% | NOK 48.7B | NOK 582.73 | 0.43% down | 20% down | ||
| 28 | Roivant SciencesROIV · Health Care | -0.53% | NOK 270.5B | NOK 373.35 | 0.53% down | 90% up | ||
| 29 | SanofiSNY · Health Care | -0.65% | NOK 1.1T | NOK 457.85 | 0.65% down | 4% down | ||
| 30 | CytokineticsCYTK · Health Care | -0.68% | NOK 69.3B | NOK 497.41 | 0.68% down | 20% down | ||
| 31 | VeradermicsMANE · Health Care | -0.71% | NOK 51B | NOK 1,209.53 | 0.71% down | 233% up | ||
| 32 | Oruka TherapeuticsORKA · Health Care | -0.73% | NOK 62.9B | NOK 927.09 | 0.73% down | 241% up | ||
| 33 | United TherapeuticsUTHR · Health Care | -0.89% | NOK 239.1B | NOK 5,612.99 | 0.89% down | 23% up | ||
| 34 | Teva Pharmaceutical IndustriesTEVA · Health Care | -1.10% | NOK 476.9B | NOK 408.68 | 1.10% down | 74% up | ||
| 35 | Regeneron PharmaceuticalsREGN · Health Care | -1.11% | NOK 950B | NOK 9,183.81 | 1.11% down | 36% up | ||
| 36 | GSKGSK · Health Care | -1.18% | NOK 945.7B | NOK 471.81 | 1.18% down | 6% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | -1.24% | NOK 47B | NOK 489.31 | 1.24% down | 44% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | -1.34% | NOK 68.4B | NOK 1,300.53 | 1.34% down | 7% down | ||
| 39 | GenmabGMAB · Health Care | -1.38% | NOK 306.4B | NOK 496.87 | 1.38% down | 70% up | ||
| 40 | PfizerPFE · Health Care | -1.40% | NOK 1.55T | NOK 272.18 | 1.40% down | 14% up | ||
| 41 | InsmedINSM · Health Care | -1.47% | NOK 255.4B | NOK 1,164.20 | 1.47% down | 40% down | ||
| 42 | Belite BioBLTE · Health Care | -1.51% | NOK 61.2B | NOK 1,506.14 | 1.51% down | 31% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | -1.59% | NOK 43.9B | NOK 401.13 | 1.59% down | 88% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | -1.64% | NOK 659.4B | NOK 206.38 | 1.64% down | 54% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | -1.73% | NOK 81.3B | NOK 101.66 | 1.73% down | 36% down | ||
| 46 | Johnson & JohnsonJNJ · Health Care | -1.92% | NOK 6.38T | NOK 2,650.42 | 1.92% down | 38% up | ||
| 47 | AstraZenecaAZN · Health Care | -2.07% | NOK 2.68T | NOK 1,730.79 | 2.07% down | 2% up | ||
| 48 | Dianthus TherapeuticsDNTH · Health Care | -2.08% | NOK 46.5B | NOK 825.81 | 2.08% down | 113% up | ||
| 49 | BeOne MedicinesONC · Health Care | -2.34% | NOK 447B | NOK 3,913.33 | 2.34% down | 17% up | ||
| 50 | Definium TherapeuticsDFTX · Health Care | -2.40% | NOK 38.1B | NOK 278.03 | 2.40% down | 169% up | ||
| 51 | Eli LillyLLY · Health Care | -2.40% | NOK 11.93T | NOK 13,395.34 | 2.40% down | 35% up | ||
| 52 | GrifolsGRFS · Health Care | -2.49% | NOK 55.5B | NOK 81.59 | 2.49% down | 1% up | ||
| 53 | AbbVieABBV · Health Care | -2.54% | NOK 4.89T | NOK 2,767.20 | 2.54% down | 26% up | ||
| 54 | NovartisNVS · Health Care | -2.61% | NOK 2.84T | NOK 1,502.69 | 2.61% down | 25% up | ||
| 55 | Bristol-Myers SquibbBMY · Health Care | -2.64% | NOK 1.18T | NOK 579.15 | 2.64% down | 34% up | ||
| 56 | ErascaERAS · Health Care | -2.78% | NOK 46B | NOK 130.93 | 2.78% down | 403% up | ||
| 57 | Novo NordiskNVO · Health Care | -3.10% | NOK 1.69T | NOK 382.41 | 3.10% down | 17% down | ||
| 58 | Corcept TherapeuticsCORT · Health Care | -3.10% | NOK 72.1B | NOK 658.36 | 3.10% down | 8% down | ||
| 59 | Merck & CoMRK · Health Care | -4.19% | NOK 3.28T | NOK 1,331.90 | 4.19% down | 51% up | ||
| 60 | Madrigal PharmaceuticalsMDGL · Health Care | -4.71% | NOK 90.6B | NOK 3,898.78 | 4.71% down | 24% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -5.09% | NOK 192.9B | NOK 1,440.15 | 5.09% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6960 NOK).
Questions and answers
Which pharmaceutical companies rank first by today's price change?
Spyre Therapeutics (+7.20%), BioMarin Pharmaceutical (+4.95%) and TG Therapeutics (+4.61%) are the top three of the 61 pharmaceutical companies ranked by today's price change as of 18 Nov 2026, 19:53 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by today's price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by today's price change have a combined market value of NOK 49.05T as of 18 Nov 2026, 19:53 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.